Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E I Polubentseva

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 11, 2005
[Aortic valve stenosis: persistence of infective agents or noninfective inflammatory process?]O V Andropova, E I Polubentseva
Terapevticheskii Arkhiv|January 1, 1993
[Physiological valvular regurgitation in healthy persons (its prevalence, hemodynamic characteristics and differential diagnosis)]E I Polubentseva, M A Stulova
Terapevticheskii Arkhiv|January 1, 1990
[The assessment of left ventricular diastolic function in patients with aortic defects]V N Anokhin, E B Kleĭmenova, E I Polubentseva
Klinicheskaia Meditsina|August 4, 2005
[Factors facilitating development of degenerative aortic valvular stenosis]O V Andropova, E I Polubentseva, V N Anokhin
Terapevticheskii Arkhiv|January 1, 1990
[Infectious endocarditis in hypertrophic cardiomyopathy]Iu I Novikov, E I Polubentseva, G N Bespalova
Klinicheskaia Laboratornaia Diagnostika|March 17, 2004
[Current technologies for enhancing efficiency of laboratory techniques]G I Nazarenko, E I Polubentseva, V V Dolgov, et al.
Klinicheskaia Meditsina|June 9, 2005
["Function-corrected" indexes for precise estimation of aortic stenosis severety]O V Andropova, E I Polubentseva, O P Bychkova, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 11, 2005
[Aortic valve stenosis: persistence of infective agents or noninfective inflammatory process?]O V Andropova, E I Polubentseva
Terapevticheskii Arkhiv|January 1, 1993
[Physiological valvular regurgitation in healthy persons (its prevalence, hemodynamic characteristics and differential diagnosis)]E I Polubentseva, M A Stulova
Terapevticheskii Arkhiv|January 1, 1990
[The assessment of left ventricular diastolic function in patients with aortic defects]V N Anokhin, E B Kleĭmenova, E I Polubentseva
Klinicheskaia Meditsina|August 4, 2005
[Factors facilitating development of degenerative aortic valvular stenosis]O V Andropova, E I Polubentseva, V N Anokhin
Terapevticheskii Arkhiv|January 1, 1990
[Infectious endocarditis in hypertrophic cardiomyopathy]Iu I Novikov, E I Polubentseva, G N Bespalova
Klinicheskaia Laboratornaia Diagnostika|March 17, 2004
[Current technologies for enhancing efficiency of laboratory techniques]G I Nazarenko, E I Polubentseva, V V Dolgov, et al.
Klinicheskaia Meditsina|June 9, 2005
["Function-corrected" indexes for precise estimation of aortic stenosis severety]O V Andropova, E I Polubentseva, O P Bychkova, et al.
Pageof 1